| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-14 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |